We are live on ! Find out more
RCUS icon

Arcus Biosciences
RCUS

157 hedge funds and large institutions have $1.59B invested in Arcus Biosciences in 2022 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 44 increasing their positions, 55 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

111% more call options, than puts

Call options by funds: $23.4M | Put options by funds: $11.1M

79% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 19

33% more funds holding in top 10

Funds holding in top 10: 6 → 8 (+2)

11% more funds holding

Funds holding: 142 → 157 (+15)

1.11% less ownership

Funds ownership: 72.35% → 71.25% (-1.1%)

20% less repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 55

23% less capital invested

Capital invested by funds: $2.06B → $1.59B (-$468M)

Holders
157
Holders Change
+15
Holders Change %
+10.56%
% of All Funds
2.48%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.13%
New
34
Increased
44
Reduced
55
Closed
19
Calls
$23.4M
Puts
$11.1M
Net Calls
+$12.3M
Net Calls Change
+$15.5M

Top Buyers

1
AllianceBernstein
AllianceBernstein
Tennessee
+$34.4M
2
APM
Avidity Partners Management
Texas
+$30.6M
3
BI
BVF Inc
California
+$18.9M
4
State Street
State Street
Massachusetts
+$18.7M
5
PA
Perceptive Advisors
New York
+$13.6M

Top Sellers

1
EC
EcoR1 Capital
California
-$75.7M
2
WP
Woodline Partners
California
-$48.4M
3
Morgan Stanley
Morgan Stanley
New York
-$39.7M
4
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
-$15M
5
Franklin Resources
Franklin Resources
California
-$14.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
ECM
76
Endurant Capital Management
California
$1.22M +$1.3M +38,650 New
Legal & General Group
77
Legal & General Group
United Kingdom
$1.17M +$644K +19,227 +108%
Citigroup
78
Citigroup
New York
$1.03M -$2.56M -76,296 -70%
CS
79
Credit Suisse
Switzerland
$1.01M -$57.7K -1,723 -5%
BFM
80
Boothbay Fund Management
New York
$972K +$1.03M +30,800 New
Osaic Holdings
81
Osaic Holdings
Arizona
$971K – – –
Barclays
82
Barclays
United Kingdom
$965K -$916K -27,336 -47%
ECM
83
ExodusPoint Capital Management
New York
$940K +$998K +29,787 New
Mirae Asset Global Investments
84
Mirae Asset Global Investments
South Korea
$939K +$997K +29,753 New
Wells Fargo
85
Wells Fargo
California
$930K -$459K -13,687 -32%
VIA
86
Vident Investment Advisory
Georgia
$919K +$163K +4,855 +20%
Millennium Management
87
Millennium Management
New York
$803K -$1.62M -48,438 -66%
MIM
88
MetLife Investment Management
New Jersey
$790K +$306K +9,127 +57%
Jane Street
89
Jane Street
New York
$785K +$833K +24,861 New
JG
90
Jefferies Group
New York
$738K +$784K +23,399 New
Prudential Financial
91
Prudential Financial
New Jersey
$737K -$10.3K -308 -1%
EGM
92
Engineers Gate Manager
New York
$737K +$783K +23,367 New
AIG
93
American International Group
New York
$702K -$52.4K -1,565 -7%
CM
94
Caption Management
Oklahoma
$686K +$728K +21,740 New
LSERS
95
Louisiana State Employees Retirement System
Louisiana
$644K +$690K +20,600 New
Citadel Advisors
96
Citadel Advisors
Florida
$628K -$4.75M -141,902 -88%
Allspring Global Investments
97
Allspring Global Investments
North Carolina
$616K -$23.5K -700 -3%
T. Rowe Price Associates
98
T. Rowe Price Associates
Maryland
$613K +$54.3K +1,622 +9%
Manulife (Manufacturers Life Insurance)
99
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$598K -$139K -4,148 -18%
VOYA Investment Management
100
VOYA Investment Management
Georgia
$558K – – –
2 3
4
5 6

RCUS Hedge Fund Activity: Q1 2022 in Review

157 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Arcus Biosciences (RCUS) for Q1 2022, worth a combined $1.59B — down 23% from $2.06B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new RCUS positions and 19 closed out — a net gain of 15 holders — while 44 added to existing stakes and 55 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $34.4M. The largest seller was EcoR1 Capital, cutting an estimated $75.7M.

  • 157 institutional investors held Arcus Biosciences (RCUS) as of Q1 2022, up from 142 in Q4 2021.
  • Funds reported $1.59B of Arcus Biosciences stock for Q1 2022, down 23% quarter-over-quarter.
  • 34 funds opened new Arcus Biosciences positions in Q1 2022 and 19 closed out, a net change of +15 holders.
  • The largest Arcus Biosciences buyer in Q1 2022 was AllianceBernstein, an estimated $34.4M added.
  • The largest Arcus Biosciences seller in Q1 2022 was EcoR1 Capital, an estimated $75.7M sold.

Based on aggregated 13F filings for Q1 2022.